Crossmark

Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study

Crossref DOI link: https://doi.org/10.1186/s12944-018-0698-4

Published Online: 2018-03-14

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Contini, Christine

Jansen, Martin

König, Brigitte

Markfeld-Erol, Filiz

Kunze, Mirjam

Zschiedrich, Stefan

Massing, Ulrich

Merfort, Irmgard

Prömpeler, Heinrich

Pecks, Ulrich

Winkler, Karl

Pütz, Gerhard https://orcid.org/0000-0002-0816-2018
Funding

Funding for this research was provided by:

B.Braun

Albert-Ludwigs-Universität Freiburg
License Information

Text and Data Mining valid from 2018-03-14
More Information

Article History

Received: 20 December 2017

Accepted: 7 March 2018

First Online: 14 March 2018

Ethics approval and consent to participate

: The study was approved by the local ethics committee at the Medical Center - University of Freiburg, (local ethics committee number: 475/12;: NCT01967355), and all patients gave informed written consent.

: Not applicable.

: KW was supported by a grant for another trial regarding apheresis by B. Braun. The authors have no other conflicts of interest to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.